格隆汇1月6日丨中国生命集团(08296.HK)公告,内容有关收购广东因微约19.46%股权涉及根据特别授权发行可换股债券须予披露及关连交易。由于股权转让协议先决条件未能达成,故收购事项并未于2024年12月31日(即股权转让协议最后截止日期)完成,股权转让协议亦因此失效。股权转让协议订约方根据股权转让协议并无任何其他责任及义务。董事认为,股权转让协议失效将不会对集团的业务、经营及财务状况造成重大...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.